Min‐Jong Kang
- Immunology top 2%
- interferon and immune responses 7
- IL-33, ST2, and ILC Pathways 7
- Physiology top 1%
- Asthma and respiratory diseases 9
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 11
- Neonatal Respiratory Health Research 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Physiology top 5%
- Asthma and respiratory diseases 9
- Emergency Medical Services top 2%
-
- Inflammasome and immune disorders 8
- Studies on Chitinases and Chitosanases 7
- Co-authors
- Chun Geun LeeJack A. EliasCharles S. Dela CruzRobert HomerBing MaChuan-Hua HeSeyedtaghi TakyarFarida Ahangari
- Journals
- American Journal of Respiratory Cell and Molecular Biology (5 papers)Journal of Clinical Investigation (4 papers)American Journal of Respiratory and Critical Care Medicine (4 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Min‐Jong Kang
61 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Immunology 1.1k
- Physiology 204
- Pulmonary and Respiratory Medicine 1.1k
- Physiology 690
- Emergency Medical Services 186
Countries citing papers authored by Min‐Jong Kang
This map shows the geographic impact of Min‐Jong Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Jong Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Jong Kang more than expected).
Fields of papers citing papers by Min‐Jong Kang
This network shows the impact of papers produced by Min‐Jong Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Jong Kang. The network helps show where Min‐Jong Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min‐Jong Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2021 | 24 | |
| 3 | 2021 | 16 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 79 | |
| 9 | 2018 | 81 | |
| 10 | 2017 | 180 | |
| 11 | 2015 | 42 | |
| 12 | 2014 | 33 | |
| 13 | 2012 | 123 | |
| 14 | 2012 | 81 | |
| 15 | 2011 | 22 | |
| 16 | [Accuracy evaluation of mammography in the breast cancer screening in Asian women: a community-based follow-up study and meta analysis]. | 2010 | 5 |
| 17 | 2010 | 87 | |
| 18 | 2008 | 178 | |
| 19 | 2007 | 123 | |
| 20 | 2003 | 150 |
About Min‐Jong Kang
Min‐Jong Kang is a scholar working on Immunology, Emergency Medical Services and Physiology, having authored 66 papers that have together received 3.7k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (9 papers), Inflammasome and immune disorders (8 papers), interferon and immune responses (7 papers), IL-33, ST2, and ILC Pathways (7 papers), Neonatal Respiratory Health Research (7 papers), Studies on Chitinases and Chitosanases (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). The work is most often cited by research in Immunology (1.1k citations), Physiology (204 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Min‐Jong Kang has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Chun Geun Lee, Jack A. Elias, Charles S. Dela Cruz, Robert Homer, Bing Ma, Chuan-Hua He, Seyedtaghi Takyar, Farida Ahangari, Carla A. Da Silva and Svetlana P. Chapoval. Their work appears in journals such as American Journal of Respiratory Cell and Molecular Biology, Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine, The Journal of Immunology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.